Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine implicated in the pathogenesis of inflammation and cancer. It is produced by various cells and circulating MIF has been identified as a biomarker for a range of diseases. Extracellular MIF mainly binds to the cluster of different...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2021-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_fccf828dca294a1fae4c27d6a57991b2 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Yongjian Wen |e author |
| 700 | 1 | 0 | |a Yongjian Wen |e author |
| 700 | 1 | 0 | |a Yongjian Wen |e author |
| 700 | 1 | 0 | |a Wenhao Cai |e author |
| 700 | 1 | 0 | |a Wenhao Cai |e author |
| 700 | 1 | 0 | |a Jingyu Yang |e author |
| 700 | 1 | 0 | |a Xianghui Fu |e author |
| 700 | 1 | 0 | |a Lohitha Putha |e author |
| 700 | 1 | 0 | |a Qing Xia |e author |
| 700 | 1 | 0 | |a John A. Windsor |e author |
| 700 | 1 | 0 | |a Anthony R. Phillips |e author |
| 700 | 1 | 0 | |a Anthony R. Phillips |e author |
| 700 | 1 | 0 | |a Joel D. A. Tyndall |e author |
| 700 | 1 | 0 | |a Dan Du |e author |
| 700 | 1 | 0 | |a Tingting Liu |e author |
| 700 | 1 | 0 | |a Wei Huang |e author |
| 700 | 1 | 0 | |a Wei Huang |e author |
| 245 | 0 | 0 | |a Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer |
| 260 | |b Frontiers Media S.A., |c 2021-03-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2021.638950 | ||
| 520 | |a Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine implicated in the pathogenesis of inflammation and cancer. It is produced by various cells and circulating MIF has been identified as a biomarker for a range of diseases. Extracellular MIF mainly binds to the cluster of differentiation 74 (CD74)/CD44 to activate downstream signaling pathways. These in turn activate immune responses, enhance inflammation and can promote cancer cell proliferation and invasion. Extracellular MIF also binds to the C-X-C chemokine receptors cooperating with or without CD74 to activate chemokine response. Intracellular MIF is involved in Toll-like receptor and inflammasome-mediated inflammatory response. Pharmacological inhibition of MIF has been shown to hold great promise in treating inflammatory diseases and cancer, including small molecule MIF inhibitors targeting the tautomerase active site of MIF and antibodies that neutralize MIF. In the current review, we discuss the role of MIF signaling pathways in inflammation and cancer and summarize the recent advances of the role of MIF in experimental and clinical exocrine pancreatic diseases. We expect to provide insights into clinical translation of MIF antagonism as a strategy for treating acute pancreatitis and pancreatic cancer. | ||
| 546 | |a EN | ||
| 690 | |a macrophage migration inhibitory factor | ||
| 690 | |a acute inflammatory response | ||
| 690 | |a toll-like receptor | ||
| 690 | |a inflammasome | ||
| 690 | |a acute pancreatitis | ||
| 690 | |a pancreatic cancer | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 12 (2021) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2021.638950/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/fccf828dca294a1fae4c27d6a57991b2 |z Connect to this object online. |